Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-25 @ 3:45 AM
NCT ID: NCT06710002
Eligibility Criteria: Inclusion Criteria: * Female * Age from 45 to 65 years. * Menopausal * Suffer dyspareunia for 3 months of evolution. * Willing to complete study questionnaires and informed consent study. Exclusion Criteria: * Pacemaker or other types of electronic implant. * Thrombophlebitis. * Skin hypersensitivity or rejection of manual contact. * Active or previous treatment with chemotherapy or radiotherapy in the pelvic area. * Wounds or burns in the pelvic area. * Allergy to nickel and chromium. * Other pelvic floor physiotherapy treatments during the study intervention. * Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention. * Surgical intervention in the pelvic area in the last 3 months. * Fibromyalgia. * Oncological processes that affect the sacrum. * Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions). * Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy). * Myelopathy and Osteomyelitis. * Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury). * Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc). * Serious mental disorder.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 45 Years
Maximum Age: 65 Years
Study: NCT06710002
Study Brief:
Protocol Section: NCT06710002